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RESUMEN: 
 
 
Introducción:  Infección genital con Chlamydia trachomatis es una de las infecciones de 
transmisión sexualmás frecuentes, afectando a la poblaciónfértil en todo el mundo.  La infección 
puede ser asintomática por lo que en algunos países se recomienda realizar tamizaje anual para la 
población en riesgo.  La infección no tratada puede causar complicaciones no solamente en la 
población no embarazada, sino que también afecta a la población embarazada, produciendo 
riesgo para rupturaprematura de membranas, partoprematuro, endometritis, conjuntivitis neonatal 
y neumonía.  
 
Materiales y Métodos: Después de obtener el consentimiento informado, 60 muestras 
endocervicales fueron obtenidas de mujeres embarazadas cursando hasta 14 semanas de edad 
gestacional, entre las edades de 18 a 36 años, sin historia previa del uso de antibióticos u óvulos 
adentro de las seis semanas previas. Las muestras fueron recolectadas de tres centros de salud en 
Quito, Ecuador.  Las muestras endocervicales fueron procesadas usando PCR.   
 
Resultados:  Cuatro de 60 sujetos fueron positivos para infección con Chlamydia trachomatis.   
Los sujetos infectados, quienes tenían entre 18 y 23 años de edad, demostraron una frecuencia 
relativa de 7% de infección con Chlamydia trachomatis en la población entre 18 y 24 años de 
edad.  Las participantes infectadas presentaron un ingreso mensual menor que la población 
general no infectada.  Adicionalmente, la población infectada reportó más casos de abortos 
espontáneos y partos normales que la población no infectada.  No se determinó una relación 
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entre la presencia de infección y el número de compañeros sexuales, infidelidad, dolor pélvico y 
presencia de secreciones vaginales. 
Conclusiones: Este estudio piloto apoya la evidencia previamente conocida que reporta que la 
frecuencia de infección con Chlamydia trachomatis es mayor en la población adolescente y de 
menores recursos econmicos.  Se necesita realizar investigaciones futuras con una población más 
amplia para determinar la prevalencia de Chlamydia trachomatis en participantes de varios 
grupos étnicos y niveles de educación.   
 
PALABRAS CLAVES: Chlamydiatrachomatis, embarazada, mujeres, Ecuador. 
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ABSTRACT: 
 
 
Background:  Genital infection with Chlamydia trachomatis is one of the most common 
sexually transmitted infections affecting reproductive population worldwide. As infection may 
be asymptomatic in majority of cases, annual screening is vital for population at risk. Untreated 
infection may cause complications not only in the non-pregnant population, but also in the 
pregnant population, producing risk for preterm rupture of membranes and labor, endometritis, 
neonatal conjunctivitis, and pneumonia.   
 
Methods:  After obtaining informed consent, 60 endocervical samples were obtained from 
pregnant women (less than 14 weeks of gestation age) between the ages of 18-36, with no history 
of use of antibiotics or ovules within the previous 6 weeks.  Samples were collected from three 
health care centers in Quito, Ecuador.  Endocervical samples were processed using PCR. 
 
Results:  Four of 60 subjects tested positive for Chlamydia trachomatis.  These subjects ranged 
in age from 18-23 years, producing a relative frequency of 7% of infection with Chlamydia 
trachomatis in the general population between 18 and 24 years of age.  The infected subjects 
presented lower monthly incomes that did the overall non-infected subjects.  Additionally, the 
infected population reported more cases of miscarriages and previous vaginal deliveries, than did 
the non-infected population. No relationship was found between infection and number of sexual 
partners, infidelity, pelvic pain, and vaginal secretions.   
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Conclusions:This pilot study supports previous evidence that frequency of infection is greater in 
adolescent population.  Future studies needed with larger population size to investigate 
prevalence of Chlamydia trachomatis in participants of various ethnic groups and education 
levels.   
 
KEY WORDS:Chlamydia trachomatis, pregnant, women, Ecuador. 
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INTRODUCTION: 
 
Chlamydia trachomatis is an intracellular bacterium that causes genital tract infections 
that have been related to serious reproductive morbidity.  The genotypes of Chlamydia 
trachomatis associated with sexual transmission are D, E, F, G; H, I, J, and K.  These genotypes 
are associated with cervicitis and urethritis, while genotypes L1, L2, L2a and L3 are associated 
with the systemic infection lymphogranulomavenereum (Lima et al., 2007).  While these 
genotypes are related to specific presentations of infection recent data suggests that chlamydial 
genital infections are asymptomatic in 50% of the male population and up to 80% in the female 
population (Lima et al., 2007), which has led to under detection of this sexually transmitted 
infection.  In 2008, it was estimated by the Center for Disease Control and Prevention that there 
were 2.8 million cases of Chlamydia trachomatis infections annually, however, only 1.2 million 
cases were reported (Satterwhite et al., 2011).  This large, undetected, asymptomatic group of 
carriers is at risk of complications and puts the rest of the general population at risk for 
transmission of sexually transmitted infections (Lima et al., 2007). 
 
Untreated chlamydial genital infections may cause complications such as pelvic inflammatory 
disease, ectopic pregnancies, tubal-factor infertility, as well as chronic pelvic pain (Satterwhite et 
al., 2011).  Research suggests that two thirds of the cases of tubal-factor infertility and one third 
of the cases of ectopic pregnancies are associated with genital chlamydial infections (Peipert, 
2003).  Chlamydia trachomatis infection in the pregnant population may cause premature rupture 
of membranes and consequently preterm labor, as well as postpartum endometritis (Peipert, 
2003).  In 2006, it was estimated that 155,000 infants were born to chlamydia-infected mothers 
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(Rahangdale et al., 2006).  It has been estimated that approximately 30 to 50% of these infants 
born to chlamydia-infected mothers will present conjunctivits, and of those who present 
conjunctivitis, at least 50% will present a nasopharyngeal infection (Peipert, 2003).   Thirty per 
cent of newborns with nasopharyngeal Chlamydia infections will develop pneumonia (Peipert, 
2003).  
While the majority of patients have asymptomatic infections, during physical examination, at 
least one third of women will show local signs of infection, including a mucopurulent discharge 
from the cervix.  In the symptomatic population of infected women, they may present with acute 
urethral syndrome, urethritis, bartholinitis, cervicitis, upper genital tract infections, perihepatitis, 
and reactive arthritis (Peipert, 2003).  Due to the possible complications and consequences of this 
sexually transmitted infection, screening programs have been implemented with a focus on 
sexually active women who present any of the following risk factors:  younger than 25 years of 
age, start of sexual intercourse at an early age, multiple sexual partners, a new sexual partner, 
black race, previous medical history of coexistent sexually transmitted infection, cervical ectopy, 
and inconsistent use of barrier contraceptive methods (Peipert, 2003).  The United States Centers 
for Disease Control and Prevention recommends screening for chlamydial genital infections 
during the first prenatal visit in all women and again in the third trimester for women who are at 
high risk (including those younger than 25 years of age) (Peipert, 2003).  The United States 
Preventive Services Task Force recommends screening for chlamydial genital infection in all 
pregnant women aged 24 years and younger.  As for pregnant women older than 24 years of age, 
the USPSTF recommends screening for those who present risk factors such as previous history 
of sexually transmitted infections, new sex partners, multiple sex partners, or those who 
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exchange sex for money or drugs.   Additionally, the USPSTF recommends screening for all 
pregnant women, regardless of age, during the third trimester (USPSTF, 2001). 
In the United States, the prevalence rates of high risk populations has been found to be anywhere 
between 6 and 20%, while prevalence rates between 4 and 12% have been reported for women 
attending family planning clinics (Peipert, 2003).  Another study states that about half of the 19 
million new sexually transmitted infections reported annually in the United States among women 
and men between the ages of 15-24, the majority of these cases were caused by Chlamydia 
trachomatis and Neisseria gonorrhoeae (Berggren et al., 2011).  Additionally it in this particular 
study, it was observed that these two sexually transmitted infections occurred most frequently in 
adolescent girls between 15 and 19 years of age (Berggren et al., 2011).  It was also shown that 
minorities were more frequently affected than Caucasians (Berggren et al., 2011).    Various 
studies demonstrate the same principle.  For example, an investigation carried out in 2004 
indicated that the prevalence rate of Chlamydia trachomatis in the United States varies according 
to ethnic group.  Caucasian adults illustrated a prevalence rate of 1.94%, while it was six times 
greater in the population of young African adults (12.54%, 95% CI: 4.68-8.91).  Similarly, in a 
group of young Native-American adults, the prevalence of chlamydia was determined to be 
10.4%, while in the Hispanic Americans, the prevalence was only 5.89% (Miller, 2004).  With 
such extreme variations in the prevalence of this sexually transmitted infection, it is important 
that each country establish adequate screening guidelines and programs to determine the 
frequency of these infections with means to decrease transmission and consequently decrease the 
consequences of untreated infections.     
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JUSTIFICATION OF STUDY: 
In today´s world, the adolescent and young adult populations are initiating sexual contact 
at a younger age, use of barrier contraceptive methodsinconsistently, and have more sexual 
partners which accounts for the rising incidence of sexually transmitted infections (Macmillan, 
1999).  For this reason it is crucial to establish guidelines for screening programs that apply to 
populations at risk for STIs.   
 
It is well known that Chlamydia trachomatis infection is the most prevalent sexually transmitted 
infection worldwide, affecting the pregnant and non-pregnant population.  However, routine use 
of screening programs for chlamydial genital infections in prenatal controls throughout countries 
of Latin America, such as Ecuador, is not a common practice.  Due	  to	  inadequate	  population	  screening,	   the	   actual	   prevalence	   of	   the	   sexually	   transmitted	   infection	   Chlamydia	  
trachomatisin	  Ecuador	   is	   still	   unknown.	   In	   countries	   surrounding	  Ecuador,	   such	   as	  Peru,	  the	  prevalence	  rate	  of	  Chlamydia	  trachomatis	  among	  pregnant	  women	  was	  found	  to	  be	  of	  33.8%	  (Portilla	  et	  al.	  	  1999).	  	  In	  Chile,	  the	  prevalence	  rate	  of	  Chlamydia	  was	  established	  to	  be	   7%	   in	   non-­‐pregnant	   young	   women	   (Huneeus	   et	   al.,	   2009),	   while	   in	   Brazil,	   the	  prevalence	  was	  reported	  to	  be	  19%	  in	  young,	  non-­‐pregnant	  women	  (Lima	  et	  al.,	  2007).	  	  In	  the	   United	   States	   and	   Europe	   the	   prevalence	   is	   4.19%	   (95% CI, 3.48% - 4.90%)(Miller, 
2004). With such extreme range of prevalence it is vital to determine the situation in Ecuador in 
order to identify risk groups and implement adequate screening and prevention programs.   
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This sexually transmitted infection must be promptly detected in order to prevent its 
gynecological and obstetrical complications, in addition to prevent any neonatal complications 
that may arise.  Early detection through screening programs will minimize the distribution of 
chlamydial genital infections.  Additionally, it will diminish the susceptibility and transmission 
of other sexually transmitted infections such as Human Immunodeficiency Virus (HIV) and 
Human Papilloma Virus (Miller, 2004).  Populations screening programs have reduced the 
incidence of PID and other complications arising from Chlamydia (Bohm, 2010).   
 
Ecuador´s predominantly Catholic population and their religious beliefs may negatively 
influence the practice of safe sex throughout the country.    Many do not acknowledge the use of 
barrier conceptive methods due to cultural and religious viewpoints.  With this said, a population 
that is beginning their sexual lives at an earlier ageand practices inconsistent use of barrier 
contraceptive methods is at risk for sexually transmitted infections.  The purpose of this 
investigation is to establish the frequency of Chlamydia trachomatis infections in a small 
population of pregnant women in the country´s capital.  If necessary, this pilot study will provide 
pertinent information for future screening programs among other Ecuadorian subpopulations, 
with the hopes to reduce the transmission of the infection and to properly educate the population 
about preventative measures.  
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OBJECTIVES: 
 
GENERAL OBJECTIVE:   
 
• To contribute to the control of infections caused by Chlamydia trachomatis in pregnant 
women in Quito, Ecuador. 
 
SPECIFIC OBJECTIVES:   
 
1) To determine the frequency of infections caused by Chlamydia	  trachomatis	  in pregnant 
women in Hospital Gineco-Obstétrico Isidro Ayora (HGOIA), Hospital Vozandes de 
Quito, and in the ClínicaUniversitaria USFQ. 
 
2) To identify the risk factors associated with infections caused by Chlamydia	  trachomatis. 
 
3) To establish the necessity of screening for infections caused by Chlamydia	  trachomatis	  
in pregnant women. 
 
4) To establish a platform to perform studies in larger populations with the intention to 
reduce chronic complications of infections caused by Chlamydia	  trachomatis. 
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BIOETHICAL ASPECTS: 
 
A research protocol and informed consent were written and all possible risks that may or 
may not affect the participants were identified.  This was then presented before the Bioethics 
Committee of theSan Francisco de Quito University who approved the study, as well as all 
informed consent forms.  Before obtaining any information from the participants of the study, it 
was explained that all information received and results obtained are confidential.  This point was 
stressed various times during the interview, as personal questions were asked about the 
participants’ sexual history and their planning or lack of planning of their actual pregnancy.  
Additionally, all participants were required to sign informed consent forms in order to 
participate.  Gynecologists and Obstetricians first examined all participants before obtaining any 
samples. Participants were instructed that the test itself does not pose any danger to their 
pregnancies.  Additionally, they were educated that in the case that the test results come back 
positive, they would be contacted so that during their next prenatal control, they could be given 
treatment.  All participants were asked if they have any known allergies to medications.  For 
those who were given treatment, possible side effects of the antibiotics were explained to the 
participants.  The participants were informed during every step of the investigation.  All 
information obtained was kept strictly confidential. 
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MATERIALS AND METHODS: 
 
STUDY POPULATION AND INSTRUMENTS: 
 
1. Participant selection: 
60 pregnant women from three hospitals in Quito, Ecuador were selected to be 
participants in this study.  These hospitals included Hospital Gineco-Obstetrico Isidro 
Ayora (a public maternity hospital), Hospital Vozandes de Quito (middle class private 
hospital), and the ClínicaUniversitaria USFQ.  The participants of the study were not 
collected in a randomized or consecutive manner.  All patients who attended these 
hospitals for prenatal control between August 2011 and March 2012 and were eligible 
were presented the opportunity to participate in the study.    
 
Inclusion criteria:  The study included Ecuadorian women of the reproductive age (18-
36 years); nulliparous or multiparous, with a pregnancy less than 14 weeks. 
 
Exclusion criteria:Women who suspect pregnancy but do not have tests to confirm; 
international pregnant women; the possibility of miscarriage; use of antibiotics or 
antifungals within six weeks of the collection of the samples; women who did not sign 
the informed consent forms.   
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2. INFORMED CONSENT: 
Previous to completing the surveys and collecting the endocervical samples, the problem 
of not having information about the prevalence of genital infections caused by Chlamydia 
trachomatis in pregnant women in Ecuador was explained to the participants.  
Additionally, it was explained to each participant, the methodology for collecting the 
samples along with the risks and benefits of performing such testing.  The participants 
were informed that in the case that they would test positive for an infection with 
Chlamydia trachomatis, she and her sexual partner would receive antibiotic treatment.  It 
was made clear that all of the information obtained during this study remains 100% 
confidential and that the participant has the right to withdraw from the study at any point 
during the investigation. Participants who accepted to be part of the study signed 
informed consent forms before any samples were collected (Annex B). 
 
3. SURVEY: 
Once participants agreed to be part of the study and signed the informed consent forms, 
they were asked questions about their gynecological history (age of menarche, date of last 
menstrual period, characteristics of menstrual periods, sexual partners, use of 
contraceptives, presence of vaginal secretions, presence of pelvic pain, etc).  At the end 
of the surveys, participants were asked to sign their name with their identification 
numbers to assure that all of the information collected is correct (Annex A). 
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4. COLLECTION AND PROCESSING OF ENDOCERVICAL SAMPLES: 
Before taking the endocervical samples, all of the materials were shown to the 
participants, ensuring that all of the instruments are sterile.  Previous to taking the 
samples, it was explained to each participant that the speculum would be inserted into the 
vaginal canal and a two small swabs would be introduced to collect endocervical cells.  
One swab was inserted into the vaginal fornix without coming in contact with the vaginal 
walls and was guided around the circumference of the cervix.  It was then minimally 
introduced into the endocervix.  The procedure was repeated with the second swab.  Once 
the sample was obtained, the swabs were placed in a sterilized tube with a transport 
medium (RemelMicroTest M4RT Transport) and labeled with the patients name, the 
date, and the hospital where the sample was collected.  The samples were then placed 
into a small cooler and transported to the microbiology laboratory at the Universidad San 
Francisco de Quito where they were processed using PCR (polymerase chain reaction).  
If the samples were not able to be delivered to the laboratory within two hours of their 
collection, they were refrigerated at 4 degree Celsius until they could be transported.  In 
the laboratory, the High Pure PCR Template Preparation Kit (Roche) was used for the 
DNA extraction from the cervical-endocervical samples.  Previous to the DNA 
extraction, the two swabs were diluted in a lysis buffer.  The LightCycler® FastStart 
DNA Master PLUS HybProbe (MOLBIOL) kit was used for the detection of Chlamydia 
trachomatis.  Every three months the equipment was calibrated using the LightCycler® 
Color Compensation Set. 
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5. CREATING A DATABASE: 
All of the information obtained in the surveys were coded and entered into a database 
using Microsoft Excel 2010.  Based on the results of the screening for Chlamydia 
trachomatis, the results were also coded and entered into the database.  
 
6. TREATMENT OF PARTICIPANTS WITH INFECTION: 
Participants who tested positive for Chlamydia trachomatis were contacted and given 
treatment for the infection.  In the initial surveys, patients were asked about the existence 
of medical allergies.  As long as the patients had no previous medical history of allergies, 
they were treated with a single dose of one gram of azithromycin.   
 
STATISTICAL ANALYSIS:  
In	  order	  to	  obtain	  a	  precision	  of	  5%,	  this	  pilot	  study	  should	  use	  62	  subjects,	  assuming	  that	  the	  prevalence	  of	  Chlamydia	  trachomatis	  in	  Quito,	  Ecuador	  is	  similar	  to	  that	  of	  the	  United	  States.	  	  	  
 N	  =	  (Zα2)x(p)x(1-­‐p)/d2	  Where	  :	  Zα2:	  1.962	  P:	  4.19%	  d2	  :	  	  5%	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So:	   N	  =	  (1.962)x(0.0419)x(1-­‐0.0419)/0.052	  =	  	  61.6	  	  
Due to the fact that the majority of the variables obtained from the survey were qualitative 
variables, the statistical analysis was performed using pivot tables in Microsoft Excel.  The 
data was then analyzed using three variables, looking for possible associations between them.  
The presence or absence of the infection was compared with the age of the subjects along 
with each of the following variables:  socio-economic income, number of sexual partners, 
suspected infidelity, use of contraceptives, pelvic pain, vaginal secretion, number of vaginal 
deliveries, and number of miscarriages.  
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RESULTS:  
60 pregnant women were asked to participate in the pilot study, with the majority of the 
subjects presenting between the ages of 25 and 36 years (Table 1).  Of these 60 subjects, four 
subjects tested positive for chlamydial genital infection, producing a 7% relative frequency of 
infection (Table 1).  
 
AgeRanges	   Non-­‐infected	  
Number	  of	  cases	  
with	  infection	  
(absolute	  frequency)	  
Relativefrequency	  
of	  infection	  
(%)	  
18-­‐20	   9	   1	   2	  
21-­‐24	   8	   3	   5	  
25-­‐36	   39	   0	   0	  
Total	   56	   4	   60	  
TABLE 1.Number of subjects who tested positive forinfection with 
Chlamydia trachomatisin various age groups. 
 
The participants used in this study were currently receiving prenatal care in one of three health 
care centers located in the country´s capital, Quito.  These health care centers included one 
public hospital, one private hospital, and one private clinic.  Due to the types of health care 
centers studied, the socio-economic status of the participants greatly varied from a monthly 
income of $200 provided by subject and partner to $4000 (Figure 1, Figure 2).    Additionally, 
the infected subjects presented lower monthly incomes, than the non-infected subjects; however, 
it should be noted that these four subjects were patients at the public maternity hospital.   
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FIGURE 1. Monthly income of the infected subjects, grouped by age. 
 
 
FIGURE 2.  Monthly income of the non-infected subjects has been grouped by age. 	  In	   terms	   of	   sex	   partners,	   the	   majority	   of	   the	   participants	   have	   had	   two	   sex	   partners.	  	  Analyzing	   this	   information	   based	   on	   presence	   of	   infection,	   75%	   of	   the	   infected	   subjects	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have	   had	   only	   one	   sex	   partner	   (Figure	   3).	   	   The	   non-­‐infected	   subjects	   presented	   one	   to	  seven	  sex	  partners;	  with	  the	  majority	  reporting	  two	  sex	  partners	  (42.8%)	  (Figure	  4,	  Figure	  5).	  	  	  
 
FIGURE 3.  Number of sex partners of the subjects infected with Chlamydia trachomatis, while 
grouped according to age. 
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FIGURE 4. Non-infected subjects by age in correlation with the number of sex partners reported. 
 
 
FIGURE 5.  Total number of sexual partners in non-infected subjects. 	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Of	  the	  60	  subjects,	  29	  suspected	  infidelity	  from	  their	  current	  partner,	  where	  28	  of	  the	  56	  non-­‐infected	   participants	   (50%)	   suspected	   infidelity	   and	   only	   one	   of	   the	   four	   infected	  subjects	  (25%)	  suspected	  infidelity	  (Figure	  6).	  	  	  	  
 
FIGURE 6.  Number of non-infected subjects who suspected infidelity is shown and grouped by 
age. 
 	  Along	   with	   infidelity,	   it	   is	   important	   to	   investigate	   the	   use	   of	   contraceptives.	   	   37	   of	   60	  participants	  (61.6%)	  used	  some	  form	  of	  contraceptives,	  previous	  to	  actual	  pregnancy.	  	  50%	  of	  the	  subjects	  infected	  with	  Chlamydia	  trachomatisdid	  not	  usecontraceptives,	  while	  35	  of	  56	  (62.5%)	  non-­‐infected	  subjects	  did	  not	  use	  any	   form	  of	  contraceptives	  (Figure	  7).	   	  The	  most	  common	  method	  of	  contraceptives	  of	   the	  remaining	  non-­‐infected	  population	   is	  oral	  contraceptive	  pills	  (Figure	  7).	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FIGURE 7.   Non-infected subjects and types of contraceptives used previous to actual 
pregnancy. 
 	  As	  far	  as	  pelvic	  pain	  during	  the	  current	  pregnancy,	  45%	  of	  the	  subjects	  did	  not	  present	  any	  form	  of	  pelvic	  pain.	  	  50%	  of	  the	  infected	  population	  did	  not	  present	  pelvic	  pain	  (Figure	  8),	  while	  44.6%	  of	  the	  non-­‐infected	  subjects	  did	  not	  present	  pelvic	  pain	  (Figure	  9,	  Figure	  10).	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FIGURE 8.  Presence or absence of pelvic pain, grouped by age, in subjects infected with 
Chlamydia trachomatis. 
 
 
FIGURE 9.  Presence or absence of pelvic pain, grouped by age, in non-infected subjects. 
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FIGURE 10.  Total of pelvic pain and no pelvic pain in non-infected subjects. 	  The	   presence	   of	   vaginal	   secretion	   exists	   in	   both	   the	   infected	   and	   non-­‐infected	   subjects.	  	  60%	  of	  the	  total	  subjects	  (infected	  and	  non-­‐infected)	  complain	  of	  vaginal	  secretions.	  	  75%	  of	   the	   subjects	   infected	  with	  Chlamydia	  trachomatis	   presented	  vaginal	   secretions	   (Figure	  11).	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FIGURE 11.  Presence or absence of vaginal secretion, grouped by age, in infected subjects. 	  58.9%	  of	  the	  non-­‐infected	  subjects	  presented	  vaginal	  secretion	  (Figure	  12,	  Figure	  13).	  	  The	  majority	  of	  those	  who	  presented	  secretion	  were	  30	  years	  of	  age	  (Figure	  12).	  	  Of	  those	  who	  did	   not	   present	   secretion,	   in	   the	   non-­‐infected	   group,	   the	  majority	   were	   28	   years	   of	   age	  (Figure	  12).	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FIGURE 12.  Presence or absence of vaginal secretion in non-infected subjects, grouped by age. 
 
	  FIGURE	   13.	   	   Total	   number	   of	   non-­‐infected	   subjects	   with	   vaginal	   secretion	   and	   without	  vaginal	  secretion.	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Of	  those	  who	  are	  infected	  with	  Chlamydia	  trachomatis,	  three	  of	  the	  four	  subjects	  have	  had	  at	  least	  one	  vaginal	  delivery	  (Figure	  14).	  
 
FIGURE 14.  Number of infected subjects who have experienced zero, one, and or previous 
vaginal deliveries. 
 	  
In terms of the non-infected study population, the number of previous vaginal deliveries ranges 
from zero to four (Figure 15).  The majority of the non-infected participants have had no 
previous vaginal deliveries (66%) (Figure 16). 
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FIGURE 15.Number of vaginal deliveries in non-infected patients, grouped according to age. 	  
	  FIGURE	  16.	  	  Total	  number	  of	  previous	  vaginal	  deliveries	  in	  non-­‐infected	  subjects.	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Finally,	  in	  terms	  of	  miscarriages,	  78.3%	  of	  the	  total	  study	  population	  has	  not	  presented	  any	  previous	  miscarriages	  (Figure	  17,	  Figure	  18,	  Figure	  19).	  	  The	  participants	  aged	  18-­‐20	  years	  of	   age	   have	   not	   presented	   any	   miscarriages	   (Figure	   17,	   Figure	   18).	   	   Of	   the	   individuals	  infected	   with	   Chlamydia	   trachomatis,	   only	   one	   participant	   has	   presented	   a	   miscarriage	  (Figure	  17).	  	  	  
 
FIGURE 17.  Number of infected subjects, by age, in relation to number of previous 
miscarriages. 	  The	   majority	   of	   the	   non-­‐infected	   subjects,	   have	   not	   reported	   previous	   miscarriages	  (78.5%)	   (Figure	   18,	   Figure	   19);	   however,	   of	   those	  who	   have	   informed	   a	   past	   history	   of	  miscarriages,	   the	   maximum	   number	   of	   miscarriages	   presented	   is	   three,	   but	   was	   only	  reported	  by	  one	  subject	  (Figure	  18).	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FIGURE 18.  Number of miscarriages of the non-infected subjects by age. 	  
	  FIGURE	  19.	  	  Total	  number	  of	  previous	  miscarriages	  in	  non-­‐infected	  population.	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DISCUSSION: 
As should be expected based on previous studies, the younger, adolescent population is 
always at greatest risk for infection with most sexually transmitted infections, such as Chlamydia 
trachomatis.  In the United States, the greatest number of sexually transmitted infections by 
Chlamydia trachomatis and Neisseria gonorrhoeae are found in adolescent girls between the 
ages of 15 and 19 years of age (Berggren et al., 2011).  While this particular pilot study did not 
investigate the prevalence of chlamydia in young women between the ages of 15-17 years of age, 
there was still a 7% prevalence rate of Chlamydia trachomatis in the population aged between 
18-23 years of age.  This prevalence rate is high enough to encourage similar investigations 
including younger subjects.       
 
Additionally, through analysis of the statistical data obtained from the surveys, the subjects who 
suffered from a genital chlamydial infection presented lower monthly incomes than those who 
were not infected.  The average monthly income of the entire study population was $998.20, 
while the mode of the monthly income was $300.  The maximum monthly income of the infected 
group was $400, while in the non-infected group; the maximum monthly income was $4000.  
This could be due to the fact that the infected subjects were actually younger subjects than the 
non-infected participants and therefore, it might be expected that their sexual partners are also 
younger.  Furthermore, it might be assumed that younger subjects and younger sexual partners 
do not obtain occupations to provide stable monthly income, thus explaining why the infected 
population produces less monthly income.  It could also be inferred that the lower monthly 
income is associated with a lower level of education; however, this statement would not be true 
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seeing as many subjects did not work due to the symptoms of pregnancy and the monthly income 
presented is only that of their partners, in the case that they are not single mothers.  Due to this 
incomplete information, future studies should investigate level of education of subject and 
partner, as well as income provided by each member.    
 
In this pilot study, the majority of those who tested positive for genital chlamydial infection 
reported previous pregnancies.  As stated previously, those were tested positive were between 
the ages of 18 and 23 years of age.  This indirectly indicates that the subjects began to have 
sexual intercourse at an even younger age, putting them at risk for sexually transmitted 
infections.  The same can be said for the number of previous miscarriages.  Similar findings were 
observed between the number of previous pregnancies and miscarriages in the non-infected 
population.  The majority of the non-infected subjects had no previous vaginal deliveries or 
miscarriages.  With this said, it can be deduced that the non-infected population began to have 
sexual intercourse at an older age than the infected subjects or that the non-infected population 
effectively used some form of contraceptives.  Surprisingly, this was not the case.  50% of the 
infected population used some form of contraceptives (25% oral contraceptives and 25% 
injections), while 35 of 56 subjects (62.5%) did not use any form of contraceptives (Figure 7). 
 
Further analysis of the statistical data revealed many relationships that different to the risk 
factors that have been established by previous studies.  For example, it can be expected that the 
infected subjects would present a sexual history with an increased number of sexual partners, in 
comparison with the non-infected participants.  This however was not the case for this particular 
study.  The participants with a genital infection caused by Chlamydia trachomatis presented a 
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mode of one sexual partner, while the non-infected group presented a mode of two sexual 
partners.  Additionally, only one infected participant suspected infidelity, while 50% of the non-
infected population suspected infidelity.  Generally, suspected infidelity would increase the 
number of sexual partners of the sexual companion of the subject, possibly putting them at 
increased risk for sexually transmitted infections; however, this information is also not as one 
would presume.  In addition, the mode for suspected infidelity in the non-infected population 
was at 28 and 30 years of age.  Typically, one would conclude that the younger the ages of the 
people in the relationship, the less mature and hence, greater possibility of infidelity; however, 
this does not appear to be the case in the population used in this pilot study.   
 
Another risk factor that presented with data that was opposite of that expected is the presence of 
pelvic pain.  Chronic pelvic pain is not a very specific symptom, but has been reported in cases 
of Chlamydia trachomatis and other sexually transmitted infections (Satterwhite et al., 2011).  
50% of the infected subjects reported pelvic pain, while 31 of 56 (55.3%) non-infected 
participants presented pelvic pain.  Previous investigations report that during pregnancy, pelvic 
pain is a very common symptom.  It has been estimated that 33-50% of pregnant women present 
pelvic girdle pain before 20 weeks of gestation and that later in the pregnancy, this pain may be 
present in up to 60-70% of pregnant women (Hilde	  et	  al., 2010).   This information suggests that 
pelvic pain is not specific for infection with Chlamydia trachomatis, and that there are various 
factors, which may cause this symptom, such as pregnancy itself.   
 
Another symptom, which may present with pregnancy, is the presence of vaginal secretions.  It is 
well known that during pregnancy, glycogen synthesis increases in the vaginal epithelial cells 
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due to the effects of estrogen levels along with increased production of lactic acid from 
glycogenolysis.  This produces a lower vaginal pH in pregnant women in comparison with non-
pregnant women; consequently producing increased amounts of Lactobacilli in the vagina (Lin et 
al., 2011).  Therefore, the 33 of 56 (58.9%) non-infected subjects who presented vaginal 
secretions are most likely due to changes in the vaginal pH due to altered hormone levels as a 
result of pregnancy.  Again, infection with Chlamydia trachomatis may be asymptomatic in the 
majority of cases; therefore, there must be another explication of vaginal secretions in the non-
infected and possibly even in the infected subjects.   
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STRENGTHS AND LIMITATIONS: 
 
One of the strengths of this study is that subjects were collected from three different 
health care facilities, including a public hospital, a private, yet accessible hospital, and a private 
clinic.   By taking samples from participants who attended these three facilities, the overall 
population of this study is more likely to be a true representation of the Quito population.  This is 
to say that the participants presented a wide range of socio-economic statuses.  It could be 
assumed that those with lower socio-economic statuses are probably related to lower levels of 
education and thus higher risk candidates for contacting sexually transmitted infections.   
 As far as the weaknesses of this study, one major weakness is the fact that the Hospital 
Gineco-Obstetrico Isidro Ayora (HGOIA) changed its policy during the middle of the 
recollection of samples and instead of accepting all pregnant patients for their first prenatal 
controls, these patients were sent to their local public health care facilities.  Due to this change, 
fewer healthy patients attended HGOIA during the first trimester of their pregnancy.  An 
additional weakness is that the participants presented a recall bias in which the information that 
they answered on the surveys could be wrong.  For example, some of the patients recalled that 
their last menstrual period was different than the date that was recorded on their clinical history.  
Another weakness associated with the response to the survey is the response bias in which the 
participants may have reported incorrect answers so as to hide any information that may lead one 
to see her differently.  For example, when asked about a history of important illnesses, subjects 
did not report infection with the human immunodeficiency virus or human papilloma virus.  It 
might also be said that there is a bias of digit preference for those participants who have had 
multiple sexual partners, but do not wish to reveal the true number, so they round the number 
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down.  Additionally, one might also say that this study possesses a bias in the selection of 
participants.  While the samples were collected from three different health care facilities, the 
majority of the patients were “mestizo.”  Perhaps the study should take into consideration the 
various ethnic groups of Ecuador and try to reproduce a population that is representative of the 
general population.  Not many indigenous or afro-Ecuadorian women were attended in any of 
these three facilities.  
 Finally, another potential weakness is that several subjects denied participation in this 
study due to the invasive method used to collect the samples.  Many patients expressed that they 
did not have a problem with the collection of blood samples or urine samples; however, the idea 
of a vaginal examination turned many away.  
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RECOMMENDATIONS: 
 
After concluding this pilot study, several recommendations can be made for future 
investigations related to this topic.  In future studies, not only should the sample size be 
increased, but also the testing sites.  Samples should be collected from patients in both public and 
private hospitals.  Additionally, samples should be collected in the different geographical regions 
of Ecuador, as there are various cultural groups within the country.  This is to say that samples 
should be collected in the coast, the sierra, and the rainforest.  In addition, it should be made a 
point to include the diverse indigenous groups of Ecuador as each group may have different 
customs.  Another important area to investigate in the future is the prevalence of certain sexually 
transmitted diseases amongst various age groups.  This particular pilot study included pregnant 
women from 18-36 years of age; however, pregnant adolescents were discarded from the study 
due to the guidelines established in the inclusion and exclusion criteria.  
 The questions posed in the survey should also be changed for future studies.  It is 
important to identify the patient´s ethnic group as well as the level of education of the participant 
and their sexual partner.  Perhaps even identifying the occupations held by both the participant 
and her sexual partner could help to identify potential risk factors for infection with sexually 
transmitted infections.  Moreover, it is important to ask about the sexual history of the participant 
and her partner.  In this type of question, the names of the sexually transmitted infections should 
be shown on the survey, as often times, certain infections or conditions are not understood to be 
sexually transmitted.   
 Another area that could be examined in future studies could be the participants’ general 
knowledge of sexually transmitted infections and how to prevent said infections.  Participants 
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could be presented questions in the survey asking what are sexually transmitted infections, how 
does one contact such infections, and how can they be prevented.  Further questioning should be 
made about the correct and incorrect use of condoms.  With this information, the investigation 
could identify areas where public and private health care employees should emphasize sexual 
education to diminish the prevalence of sexually transmitted infections. 
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CONCLUSION: 
Four of the 60 subjects who were found at the time of screening to be less than 14 weeks 
pregnant, were found to test positive for a genital infection with Chlamydia trachomatis.  This is 
to say that there is an absolute frequency of genital chlamydial infection of 4% in the study 
population and a relative frequency of 7% of the general population in women between the ages 
of 18-24 years.  There was not a significant relationship between testing positive for Chlamydia 
trachomatis and the presence of pelvic pain, vaginal secretion, number of sexual partners, or 
suspected infidelity.  There was however, a rather important relationship between previous 
vaginal births and miscarriages in relation to the age of the infected participants.  Additionally, 
there was a significant relationship, which deserves further investigation, between the infected 
subjects and their reported monthly income.  As this is a pilot study, future investigations should 
be carried out in a much larger population, diverse population including the various geographical 
regions of Ecuador.  Additional investigations may be created with the emphasis of detecting the 
prevalence of Chlamydia trachomatis in the adolescent population. 
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ANNEXES: 
 
Annex A:  Survey. 
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Annex B:  Informed consent form approved by the Bioethics Committee of the Universidad San 
Francisco de Quito. 
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